vs
Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $138.0M, roughly 1.3× COASTAL FINANCIAL CORP). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -5.8%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -3.6%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
CCB vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.0M | $185.2M |
| Net Profit | — | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 12.4% | 8.6% |
| Net Margin | — | 0.9% |
| Revenue YoY | -5.8% | 23.7% |
| Net Profit YoY | — | -88.5% |
| EPS (diluted) | $0.84 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $138.0M | $185.2M | ||
| Q3 25 | $144.7M | $169.1M | ||
| Q2 25 | $119.4M | $154.7M | ||
| Q1 25 | $139.5M | $125.2M | ||
| Q4 24 | $146.5M | $149.7M | ||
| Q3 24 | $151.1M | $141.5M | ||
| Q2 24 | $135.3M | $126.7M | ||
| Q1 24 | $148.4M | $110.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | $13.6M | $17.3M | ||
| Q2 25 | $11.0M | $-24.4M | ||
| Q1 25 | $9.7M | $-21.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | $13.5M | $-6.7M | ||
| Q2 24 | $11.6M | $-15.7M | ||
| Q1 24 | $6.8M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | 12.4% | 8.6% | ||
| Q3 25 | 12.4% | 20.3% | ||
| Q2 25 | 12.0% | -6.1% | ||
| Q1 25 | 8.4% | -6.3% | ||
| Q4 24 | 11.7% | 10.7% | ||
| Q3 24 | 10.8% | 15.3% | ||
| Q2 24 | 11.1% | 11.8% | ||
| Q1 24 | 5.9% | -25.1% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 9.4% | 10.2% | ||
| Q2 25 | 9.2% | -15.8% | ||
| Q1 25 | 7.0% | -17.3% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | 8.9% | -4.8% | ||
| Q2 24 | 8.6% | -12.4% | ||
| Q1 24 | 4.6% | -43.9% |
| Q4 25 | $0.84 | $0.00 | ||
| Q3 25 | $0.88 | $0.06 | ||
| Q2 25 | $0.71 | $-0.08 | ||
| Q1 25 | $0.63 | $-0.07 | ||
| Q4 24 | $0.95 | $0.05 | ||
| Q3 24 | $0.97 | $-0.02 | ||
| Q2 24 | $0.84 | $-0.05 | ||
| Q1 24 | $0.50 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $491.0M | $274.2M |
| Total Assets | $4.7B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | — | $263.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | — | $249.8M | ||
| Q2 24 | — | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $491.0M | $274.2M | ||
| Q3 25 | $475.3M | $230.4M | ||
| Q2 25 | $461.7M | $204.3M | ||
| Q1 25 | $449.9M | $193.6M | ||
| Q4 24 | $438.7M | $194.0M | ||
| Q3 24 | $331.9M | $178.8M | ||
| Q2 24 | $316.7M | $132.5M | ||
| Q1 24 | $303.7M | $130.7M |
| Q4 25 | $4.7B | $949.9M | ||
| Q3 25 | $4.6B | $868.8M | ||
| Q2 25 | $4.5B | $815.3M | ||
| Q1 25 | $4.3B | $789.8M | ||
| Q4 24 | $4.1B | $785.0M | ||
| Q3 24 | $4.1B | $786.6M | ||
| Q2 24 | $4.0B | $749.5M | ||
| Q1 24 | $3.9B | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $254.6M | $16.3M |
| Free Cash FlowOCF − Capex | $246.1M | $16.0M |
| FCF MarginFCF / Revenue | 178.3% | 8.6% |
| Capex IntensityCapex / Revenue | 6.1% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $436.4M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $254.6M | $16.3M | ||
| Q3 25 | $59.0M | $35.7M | ||
| Q2 25 | $66.0M | $-26.5M | ||
| Q1 25 | $71.7M | $7.8M | ||
| Q4 24 | $259.8M | $-3.9M | ||
| Q3 24 | $62.6M | $-23.0M | ||
| Q2 24 | $72.1M | $22.7M | ||
| Q1 24 | $56.8M | $-29.7M |
| Q4 25 | $246.1M | $16.0M | ||
| Q3 25 | $57.4M | $35.3M | ||
| Q2 25 | $64.0M | $-28.9M | ||
| Q1 25 | $68.9M | $7.5M | ||
| Q4 24 | $249.9M | $-4.2M | ||
| Q3 24 | $60.2M | $-23.3M | ||
| Q2 24 | $69.5M | $21.6M | ||
| Q1 24 | $55.0M | $-31.5M |
| Q4 25 | 178.3% | 8.6% | ||
| Q3 25 | 39.7% | 20.9% | ||
| Q2 25 | 53.6% | -18.7% | ||
| Q1 25 | 49.4% | 6.0% | ||
| Q4 24 | 170.6% | -2.8% | ||
| Q3 24 | 39.8% | -16.5% | ||
| Q2 24 | 51.3% | 17.0% | ||
| Q1 24 | 37.1% | -28.5% |
| Q4 25 | 6.1% | 0.2% | ||
| Q3 25 | 1.2% | 0.2% | ||
| Q2 25 | 1.7% | 1.6% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 6.8% | 0.2% | ||
| Q3 24 | 1.6% | 0.3% | ||
| Q2 24 | 1.9% | 0.9% | ||
| Q1 24 | 1.2% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 4.34× | 2.06× | ||
| Q2 25 | 5.99× | — | ||
| Q1 25 | 7.37× | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | 4.65× | — | ||
| Q2 24 | 6.22× | — | ||
| Q1 24 | 8.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
